| Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer | Cellular and molecular life sciences |  | | 2023 | 130 | 389 |
|
| Optimized low‐dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatment | Molecular Oncology | | | 2020 | 449 | 204 |
|
| Integrating Phenotypic Search and Phosphoproteomic Profiling of Active Kinases for Optimization of Drug Mixtures for RCC Treatment | Cancers | | | 2020 | 258 | 149 |
|
| Optimized Combination of HDACI and TKI Efficiently Inhibits Metabolic Activity in Renal Cell Carcinoma and Overcomes Sunitinib Resistance | Cancers | | | 2020 | 382 | 372 |
|
| Drug-Drug Interactions of Irinotecan, 5-Fluorouracil, Folinic Acid and Oxaliplatin and Its Activity in Colorectal Carcinoma Treatment | Molecules | | | 2020 | 391 | 362 |
|
| Challenges and considerations in designing multidrug combinations for cancer treatment | | | | 2020 | 724 | 428 |
|
| Identification of a Synergistic Multi-Drug Combination Active in Cancer Cells via the Prevention of Spindle Pole Clustering | Cancers | | | 2019 | 549 | 355 |
|
| Short-term 3D culture systems of various complexity for treatment optimization of colorectal carcinoma | Scientific Reports | | | 2019 | 454 | 283 |
|
| Epigenetic approach for angiostatic therapy: promising combinations for cancer treatment | Angiogenesis | | | 2017 | 308 | 522 |
|
